Search

Kwang-su Yang

Examiner (ID: 9026, Phone: (571)270-7307 , Office: P/2691 )

Most Active Art Unit
2691
Art Unit(s)
2629, 2623, 2691, 2618
Total Applications
875
Issued Applications
616
Pending Applications
53
Abandoned Applications
219

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11625832 [patent_doc_number] => 20170136022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/275163 [patent_app_country] => US [patent_app_date] => 2016-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12732 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15275163 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/275163
SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR Sep 22, 2016 Abandoned
Array ( [id] => 11381583 [patent_doc_number] => 20170007639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'COLON CLEANSING OF RESIDUAL STOOL AND SECRETIONS DURING COLONOSCOPY' [patent_app_type] => utility [patent_app_number] => 15/273376 [patent_app_country] => US [patent_app_date] => 2016-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10211 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15273376 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/273376
COLON CLEANSING OF RESIDUAL STOOL AND SECRETIONS DURING COLONOSCOPY Sep 21, 2016 Abandoned
Array ( [id] => 13409907 [patent_doc_number] => 20180256496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-13 [patent_title] => CONTROLLED-RELEASE FORMULATIONS [patent_app_type] => utility [patent_app_number] => 15/761053 [patent_app_country] => US [patent_app_date] => 2016-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13555 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761053 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/761053
CONTROLLED-RELEASE FORMULATIONS Sep 15, 2016 Abandoned
Array ( [id] => 11704496 [patent_doc_number] => 20170172995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'Pharmaceutical compositions of Nicotine and process for preparation thereof' [patent_app_type] => utility [patent_app_number] => 15/265765 [patent_app_country] => US [patent_app_date] => 2016-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6914 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15265765 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/265765
Pharmaceutical compositions of Nicotine and process for preparation thereof Sep 13, 2016 Abandoned
Array ( [id] => 14243885 [patent_doc_number] => 10272125 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-30 [patent_title] => Transdermal delivery of cannabidiol with other active moieties including cannabinoids [patent_app_type] => utility [patent_app_number] => 15/265823 [patent_app_country] => US [patent_app_date] => 2016-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 10437 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15265823 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/265823
Transdermal delivery of cannabidiol with other active moieties including cannabinoids Sep 13, 2016 Issued
Array ( [id] => 11727853 [patent_doc_number] => 20170189296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'SUNSCREEN COMPOSITIONS WITH IMPROVED WATER RESISTANCE OF UVA SUNSCREEN ACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 15/264003 [patent_app_country] => US [patent_app_date] => 2016-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7172 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15264003 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/264003
Sunscreen compositions with improved water resistance of UVA sunscreen active agents Sep 12, 2016 Issued
Array ( [id] => 11497677 [patent_doc_number] => 20170071862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-16 [patent_title] => 'PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 15/260643 [patent_app_country] => US [patent_app_date] => 2016-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 36192 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260643 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/260643
Protecting oral overdose with abuse deterrent immediate release formulations Sep 8, 2016 Issued
Array ( [id] => 11491473 [patent_doc_number] => 20170065659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'COMPOSITION FOR USE IN TREATING AND/OR PREVENTING HUMAN CONDITION, DISORDER OR DISEASES' [patent_app_type] => utility [patent_app_number] => 15/256852 [patent_app_country] => US [patent_app_date] => 2016-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5472 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15256852 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/256852
COMPOSITION FOR USE IN TREATING AND/OR PREVENTING HUMAN CONDITION, DISORDER OR DISEASES Sep 5, 2016 Abandoned
Array ( [id] => 13761027 [patent_doc_number] => 10172842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => Sustained release oral dosage form containing dalfampridine [patent_app_type] => utility [patent_app_number] => 15/256636 [patent_app_country] => US [patent_app_date] => 2016-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6499 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15256636 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/256636
Sustained release oral dosage form containing dalfampridine Sep 4, 2016 Issued
Array ( [id] => 11443155 [patent_doc_number] => 20170044176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'CRYSTALLINE FORM OF TIOTROPIUM BROMIDE WITH LACTOSE' [patent_app_type] => utility [patent_app_number] => 15/244122 [patent_app_country] => US [patent_app_date] => 2016-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3530 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15244122 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/244122
Crystalline form of tiotropium bromide with lactose Aug 22, 2016 Issued
Array ( [id] => 13790701 [patent_doc_number] => 20190008889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => AGENT TO BE APPLIED TO OPHTHALMIC DEVICE [patent_app_type] => utility [patent_app_number] => 15/753886 [patent_app_country] => US [patent_app_date] => 2016-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753886 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/753886
AGENT TO BE APPLIED TO OPHTHALMIC DEVICE Aug 18, 2016 Abandoned
Array ( [id] => 12111796 [patent_doc_number] => 09867774 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-01-16 [patent_title] => 'Body lotion' [patent_app_type] => utility [patent_app_number] => 15/238420 [patent_app_country] => US [patent_app_date] => 2016-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2623 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15238420 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/238420
Body lotion Aug 15, 2016 Issued
Array ( [id] => 13672417 [patent_doc_number] => 20160374942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => GELLING AGENT-BASED DOSAGE FORM [patent_app_type] => utility [patent_app_number] => 15/238070 [patent_app_country] => US [patent_app_date] => 2016-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25287 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15238070 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/238070
GELLING AGENT-BASED DOSAGE FORM Aug 15, 2016 Abandoned
Array ( [id] => 14372183 [patent_doc_number] => 20190160004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-30 [patent_title] => IMPROVEMENTS IN CANCER TREATMENT [patent_app_type] => utility [patent_app_number] => 16/091688 [patent_app_country] => US [patent_app_date] => 2016-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7843 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091688 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/091688
IMPROVEMENTS IN CANCER TREATMENT Jul 27, 2016 Abandoned
Array ( [id] => 11269157 [patent_doc_number] => 20160331704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => 'Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same' [patent_app_type] => utility [patent_app_number] => 15/220308 [patent_app_country] => US [patent_app_date] => 2016-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15253 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15220308 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/220308
Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same Jul 25, 2016 Abandoned
Array ( [id] => 14243887 [patent_doc_number] => 10272126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-30 [patent_title] => Nanoparticle-stabilized microcapsules, dispersions comprising nanoparticle-stabilized microcapsules, and method for the treatment of bacterial biofilms [patent_app_type] => utility [patent_app_number] => 15/216134 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 28 [patent_no_of_words] => 10001 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15216134 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/216134
Nanoparticle-stabilized microcapsules, dispersions comprising nanoparticle-stabilized microcapsules, and method for the treatment of bacterial biofilms Jul 20, 2016 Issued
Array ( [id] => 11419839 [patent_doc_number] => 20170027984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'TREATMENT OF ENTERIC STRESS FROM HEAT AND INFECTION IN HUMANS AND ANIMALS BY SUPPLEMENTATION WITH ZINC AND BUTYRIC ACID' [patent_app_type] => utility [patent_app_number] => 15/198833 [patent_app_country] => US [patent_app_date] => 2016-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5452 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15198833 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/198833
Treatment of enteric stress from heat and infection in humans and animals by supplementation with zinc and butyric acid Jun 29, 2016 Issued
Array ( [id] => 11419681 [patent_doc_number] => 20170027825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'COSMETIC COMPOSITION' [patent_app_type] => utility [patent_app_number] => 15/197283 [patent_app_country] => US [patent_app_date] => 2016-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11215 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15197283 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/197283
COSMETIC COMPOSITION Jun 28, 2016 Abandoned
Array ( [id] => 12466179 [patent_doc_number] => 09987300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-05 [patent_title] => Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections [patent_app_type] => utility [patent_app_number] => 15/180603 [patent_app_country] => US [patent_app_date] => 2016-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8156 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15180603 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/180603
Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections Jun 12, 2016 Issued
Array ( [id] => 15420589 [patent_doc_number] => 10543196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-28 [patent_title] => Oral dosage forms of bendamustine [patent_app_type] => utility [patent_app_number] => 15/174467 [patent_app_country] => US [patent_app_date] => 2016-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9247 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15174467 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/174467
Oral dosage forms of bendamustine Jun 5, 2016 Issued
Menu